Oxford-AstraZenecom's new crown vaccine was approved by the British Medicines and Healthcare Products Authority (MHRA) on the 30th, will be officially put into clinical use for mass vaccination.
is the second new crown vaccine approved in the UK after Pfizer in the US.
British Prime Minister Boris Johnson tweeted the same day, "This is great news and a victory for British science."
now we will act as quickly as possible to vaccinate as many people as possible.
," Matthew Hancock, the health secretary, told the media.
" Hancock said the Oxford vaccine would be available on 4 January and the NHS would be able to carry out mass vaccinations as quickly as possible.
vaccine provides a way out of the new crown pandemic in the UK by next spring, when millions of vulnerable people will be protected.
, the UK's chief medical officer, praised the "considerable collective effort that has brought us to this point and paid tribute to british scientists."
british media rushed to report that the UK had the most exciting news of the year 2020.
the BBC said the approval of the Oxford vaccine for use in the UK was a landmark moment that would lead to a large-scale "immunization campaign LinkedIn to "bring life back to normal."
the Sun described the Oxford vaccine as a "hope" for the UK, with the Guardian describing it as "vital."
Hancock said the results showed that the Oxford vaccine, developed by Oxford University in collaboration with AstraZeneca, had an average effectiveness of 70 per cent, with 62 per cent and 90 per cent effectiveness of the two doses, respectively, and a recommended interval of 12 weeks between the first and second doses.
is "very helpful" in getting more people immunized with the first dose.
, oxford vaccines are cheaper than others, are easier to mass produce, can be stored in regular refrigerators and are easier to deliver to nursing homes and general clinics.
, the UK government has ordered 100m doses of the Oxford vaccine, enough to vaccinate 50m people, who make up about 73 per cent of the UK population.
Zhang Mengqi Zhangping Source: China News Network Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Mets Medicine" or "Source: MedSci Original" are owned by Mace Medical, and are not authorized to reproduce by any media, website or individual, and must be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
at the same time reproduced content does not represent the position of this site.
leave a message here